Could this ASX 200 share be in for a $1.7 billion boost?

The ASX 200 healthcare stock is reported to be considering selling some high value assets.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) listed Ramsay Health Care Ltd (ASX: RHC) is recovering from the two-year lows its share price hit on 26 September.

That low point came after takeover negotiations with a consortium of financial investors led by KKR failed to reach an agreement.

The ASX 200 healthcare share continued to trade lower over the following days. But the company's share price has rebounded 14% since 28 September. Shares are currently swapping hands for $64.26 apiece.

Some of that lift may be driven by speculation that Ramsay could be planning to sell a goodly portion of its property assets alongside its stake in European hospital operator Ramsay Sante.

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.

Image source: Getty Images

A possible $1.7 billion boost for this ASX 200 stock

Citing unnamed sources close to Ramsay, The Australian reports that it understands the ASX 200 healthcare stock is weighing up selling 25% of its real estate assets.

Ramsay Sante, which operates 210 facilities – including primary care units, specialist clinics, and hospitals in Denmark, Norway, Sweden, and Italy – may also be in the mix.

Should Ramsay Healthcare opt to sell its $1.7 billion majority stake in Ramsay Sante and property assets, Macquarie analysts believe the company's share price could see a healthy boost, improving the stock's return on invested capital.

According to Macquarie (courtesy of The Australian):

Applying a multiple of 12.5 times earnings before interest, tax, depreciation and amortisation for the Australian business, combined with Ramsay Sante sale proceeds, would provide a valuation of about $72.00, 15 per cent ahead of the current share price.

With some recent gains posted by the ASX 200 healthcare company, a $72.00 valuation represents a 12% premium on the share price at the time of writing.

Ramsay share price snapshot

The Ramsay share price has enjoyed a strong month, up almost 14%. That outpaces the 7% monthly gain posted by the ASX 200.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man thinks very carefully about his money and investments.
Healthcare Shares

At under $100 each, Cochlear shares look like a bargain: Here's why

Cochlear Ltd (ASX: COH) shares have now crashed 63% for the year-to-date.

Read more »

A doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

3 ASX 200 shares I'd buy for the future of healthcare

Healthcare investing often requires patience, but I think the sector can produce some excellent long-term winners.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

What does a takeover in the US tell us about the value of Telix shares?

Currently there seems to be a steep discount on this stock.

Read more »

A woman sleeps peacefully in bed with a smile on her face as though she is very satisfied about something.
Healthcare Shares

The global obesity drug boom could be bigger than investors realise for this ASX stock

ResMed shares are down in 2026 on GLP-1 fears.

Read more »

A man has a surprised and relieved expression on his face.
Healthcare Shares

Bell Potter says this ASX 300 share could rise 80%+

The broker believes an impending announcement could put a rocket under this share if it is positive.

Read more »

Medical ASX share price fall represented by worried looking patient awaiting vaccine injection.
Opinions

Under $100, are CSL shares finally too cheap to ignore?

CSL shares are back below $100 after a brutal sell-off.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Can this giant produce healthy returns or is there more downside to come?

Read more »

a nurse wearing a medical mask prepares a patient for a blood donation in a surgical setting.
Healthcare Shares

What is Morgan's updated view on this red hot ASX healthcare stock?

This company released some exciting results.

Read more »